Developmental Medicine and Child Neurology

Article	Citations
Global prevalence of cerebral palsy: A systematic analysis	149
Interventions to improve physical function for children and young people with cerebral palsy: international clinical practice guideline	95
Epidemiology of cerebral palsy in low‐ and middle‐income countries: preliminary findings from an international multi‐centre cerebral palsy register	62
New‐onset refractory status epilepticus and febrile infection‐related epilepsy syndrome	46
Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta‐analysis	45
Functioning, participation, and quality of life in children with intellectual disability: an observational study	43
Inhibitory control and impulsive responses in neurodevelopmental disorders	39
New clinical needs and strategies for care in children with neurodisability during COVID‐19	39
Virtual reality rehabilitation in children with brain injury: a randomized controlled trial	39
Fetal movements: the origin of human behaviour	38
Neurodivergence‐informed therapy	36
Current understanding of febrile seizures and their long‐term outcomes	36
Early intervention evidence for infants with or at risk for cerebral palsy: an overview of systematic reviews	36
Prevention and management of respiratory disease in young people with cerebral palsy: consensus statement	35
Avoidant/restrictive food intake disorder and autism spectrum disorder: clinical implications for assessment and management	35
Avoidant/restrictive food intake disorder and severe food selectivity in children and young people with autism: A scoping review	35
Barriers and facilitators of physical activity participation for young people and adults with childhood‐onset physical disability: a mixed methods systematic review	34
Cerebral visual impairment‐related vision problems in primary school children: a cross‐sectional survey	34
Cognitive and motor function in developmental coordination disorder	34
Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme	33
Hammersmith Infant Neurological Examination for infants born preterm: predicting outcomes other than cerebral palsy	32
Risk factors in early life for developmental coordination disorder: a scoping review	32
Combination treatments with therapeutic hypothermia for hypoxic‐ischemic neuroprotection	31
Visual function subtyping in children with early‐onset cerebral visual impairment	29
Automated movement recognition to predict motor impairment in high‐risk infants: a systematic review of diagnostic test accuracy and meta‐analysis	28

Air pollution and neurological development in children	28
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome	27
Nintendo Wii Balance Board therapy for postural control in children with cerebral palsy: a systematic review and meta‐analysis	26
Effects of extreme weather events on child mood and behavior	26
Quality appraisal of systematic reviews of interventions for children with cerebral palsy reveals critically low confidence	25
Measurement properties of the Gross Motor Function Classification System, Gross Motor Function Classification System‐Expanded & Revised, Manual Ability Classification System, and Communication Fun	25
Measuring skeletal muscle morphology and architecture with imaging modalities in children with cerebral palsy: a scoping review	25
24‐hour activity for children with cerebral palsy: a clinical practice guide	25
Participation of young people with disabilities and/or chronic conditions in low‐ and middle‐income countries: a scoping review	25
Clinical tools used in young infants born very preterm to predict motor and cognitive delay (not cerebral palsy): a systematic review	24
Sleep problems in children with cerebral palsy and their parents	24
Speech in children with cerebral palsy	24
Early intervention for very young children with or at high likelihood for autism spectrum disorder: An overview of reviews	24
Severe speech impairment is a distinguishing feature of FOXP1‐related disorder	24
Locomotor and robotic assistive gait training for children with cerebral palsy	23
The F‐words for child development: functioning, family, fitness, fun, friends, and future	23
Early visual training and environmental adaptation for infants with visual impairment	23
Physical therapy in children with cerebral palsy in Brazil: a scoping review	23
Neurological effects of COVID‐19 in infants and children	22
Physical therapy interventions to improve sitting ability in children with or at‐risk for cerebral palsy: a systematic review and meta‐analysis	22
Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat‐treatment study	22
Assisted reproductive technology: Short‐ and long‐term outcomes	21
Development of a new comorbidity index for adults with cerebral palsy and comparative assessment with common comorbidity indices	21
Brain, cognition, and language development in spinal muscular atrophy type 1: a scoping review	21
Fenfluramine as antiseizure medication for epilepsy	20
Machine learning to quantify habitual physical activity in children with cerebral palsy	20
Nutritional status of children with cerebral palsy attending rehabilitation centers	20
Health service use among adults with cerebral palsy: a mixed‐methods systematic review	20
Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening	20
Focal epilepsy in SCN1A‐mutation carrying patients: is there a role for epilepsy surgery?	20
Bilateral transcranial magnetic stimulation of the supplementary motor area in children with Tourette syndrome	19
Psychosocial impact of genetic testing on parents of children with developmental and epileptic encephalopathy	19
Autism and attention‐deficit/hyperactivity disorder in children with cerebral palsy: high prevalence rates in a population‐based study	19
Genetic testing in individuals with cerebral palsy	19
Consensus clinical management guideline for beta‐propeller protein‐associated neurodegeneration	18
Communication disorders in young children with cerebral palsy	18
Retinopathy of prematurity	18
Progressive resistance training for adolescents with cerebral palsy: the STAR randomized controlled trial	18
Functional electrical stimulation cycling, goal‐directed training, and adapted cycling for children with cerebral palsy: a randomized controlled trial	18
Whitney Comorbidity Index to monitor health status for adults with cerebral palsy: validation and thresholds to assist clinical decision making	18
Autism and attention‐deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1	18
Hand–arm bimanual intensive therapy and daily functioning of children with bilateral cerebral palsy: a randomized controlled trial	18
Leisure‐time physical activity interventions for children and adults with cerebral palsy: a scoping review	18
Emerging signs of autism spectrum disorder in infancy: Putative neural substrate	18
Childhood neurodevelopmental disorders and maternal hypertensive disorder of pregnancy	18
Pain in children with dyskinetic and mixed dyskinetic/spastic cerebral palsy	18
Early motor outcomes in infants with critical congenital heart disease are related to neonatal brain development and brain injury	18
Epidemiology of cerebral palsy in Sumba Island, Indonesia	18
Cytokine dysregulation in children with cerebral palsy	18
Clinical use of the Insight Inventory in cerebral visual impairment and the effectiveness of tailored habilitational strategies	17

Qualitative health research in the fields of developmental medicine and child neurology	17
Prevalence of pain and interference with daily activities and sleep in adults with cerebral palsy	17
Early intervention for children with/at risk of developmental coordination disorder: a scoping review	17
Definition and diagnosis of cerebral palsy in genetic studies: a systematic review	17
Motor imagery and action observation for predictive control in developmental coordination disorder	17
Early developmental milestones in Duchenne muscular dystrophy	17
Motor function and safety after allogeneic cord blood and cord tissue‐derived mesenchymal stromal cells in cerebral palsy: An open‐label, randomized trial	17
Perinatal care with a view to preventing cerebral palsy	17
Early identification of children with/at risk of developmental coordination disorder: a scoping review	17
Anti‐dopamine D2 receptor antibodies in chronic tic disorders	16
Physical rehabilitation interventions in children with acquired brain injury: a scoping review	16
Sunflower syndrome: a poorly understood photosensitive epilepsy	16
Incidence and risk factors of cerebral sinovenous thrombosis in infants	16
Cognitive empathy across the lifespan	16
Evolution of bulbar function in spinal muscular atrophy type 1 treated with nusinersen	16
Methodological quality of clinical guidelines for universal newborn hearing screening	16
Poster Presentations	16
Disparity of child/parent‐reported quality of life in cerebral palsy persists into adolescence	15
Development of an ICF Core Set for adults with cerebral palsy: capturing their perspective on functioning	15
Research priorities for children with neurological impairment and medical complexity in high‐income countries	15
Early motor repertoire and neurodevelopment at 2 years in infants born extremely preterm or extremely‐low‐birthweight	15
Fenfluramine for seizures associated with Sunflower syndrome	15
Cerebrospinal fluid metabolites in tryptophan‐kynurenine and nitric oxide pathways: biomarkers for acute neuroinflammation	15
Prenatal methadone exposure and child developmental outcomes in 2‐year‐old children	15
Levetiracetam as the first‐line treatment for neonatal seizures: a systematic review and meta‐analysis	15
Interventions and lower‐limb macroscopic muscle morphology in children with spastic cerebral palsy: a scoping review	15
Assessing communicative participation in preschool children with the Focus on the Outcomes of Communication Under Six: a scoping review	14
ATP1A3 variants and slowly progressive cerebellar ataxia without paroxysmal or episodic symptoms in children	14
Stem cell therapies in cerebral palsy and autism spectrum disorder	14
Declining trends in birth prevalence and severity of singletons with cerebral palsy of prenatal or perinatal origin in Australia: A population‐based observational study	14
Risk factors for academic difficulties in children with myelin oligodendrocyte glycoprotein antibody‐associated acute demyelinating syndromes	14
Cerebral palsy is a sensorimotor disorder	14
Diagnostic yield and treatment impact of whole‐genome sequencing in paediatric neurological disorders	14
The neurodevelopmental spectrum of congenital Zika infection: a scoping review	14
Cerebral palsy in twins and higher multiple births: a Europe‐Australia population‐based study	14
Inequities in quality and safety outcomes for hospitalized children with intellectual disability	13
Hand function and self‐care in children with cerebral palsy	13
Classification of pain in children with cerebral palsy	13
Hammersmith Infant Neurological Examination and long‐term cognitive outcome in children born very preterm	13
Changes in walking ability, intellectual disability, and epilepsy in adults with cerebral palsy over 50 years: a population‐based follow‐up study	13
Self‐care performance in children with cerebral palsy: a longitudinal study	13
Congenital anomalies in children with pre‐ or perinatally acquired cerebral palsy: an international data linkage study	13
Muscle synergy structure and gait patterns in children with spastic cerebral palsy	13
Antenatal diagnosis of fetal intraventricular hemorrhage: systematic review and meta‐analysis	13
Epilepsy in children with cerebral palsy: a data linkage study	13
Functional development in children with cerebral palsy in Uganda: population‐based longitudinal cohort study	13
Predictive validity of the Hand Assessment for Infants in infants at risk of unilateral cerebral palsy	12
Development of gross motor capacity and mobility performance in children with cerebral palsy: a longitudinal study	12
The subtypes of developmental coordination disorder	12
Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure	12
Effect of pain on mood affective disorders in adults with cerebral palsy	12
The prognostic value of neonatal conventional‐EEG monitoring in hypoxic‐ischemic encephalopathy during therapeutic hypothermia	12
Paediatric epilepsy and cognition	12
Participation predictors for leisure‐time physical activity intervention in children with cerebral palsy	12
Rehabilitation interventions in Rett syndrome: a scoping review	12
Concurrent validity of the Warner Initial Developmental Evaluation of Adaptive and Functional Skills and the Bayley Scales of Infant and Toddler Development, Third Edition	12
Deep brain stimulation reduces pain in children with dystonia, including in dyskinetic cerebral palsy	12
Outcomes for gastrostomy‐fed children and their parents: qualitative findings from the ‘Your Tube’ study	12
Developing a fidelity measure of early intervention programs for children with neuromotor disorders	12
IQ predictors in pediatric opsoclonus myoclonus syndrome: a large international cohort study	12
Point prevalence and motor function of children and adolescents with cerebral palsy in Scandinavia and Scotland: a CP‐North study	12
Microstructural changes in the spinal cord of adults with cerebral palsy	12
Hammersmith Infant Neurological Examination in infants born at term: Predicting outcomes other than cerebral palsy	11
Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 2, risks of adverse outcome in common anomalies	11
Differential diagnosis of progressive intellectual and neurological deterioration in children	11
Caregiver assessment of quality of life in individuals with genetic developmental and epileptic encephalopathies	11
Impacts of health care service changes implemented due to COVID‐19 on children and young people with long‐term disability: A mapping review	11
Diagnostic approach to paediatric movement disorders: a clinical practice guide	11
Long‐term impact of COVID‐19 on disabled children	11
Somatosensory deficits and neural correlates in cerebral palsy: a scoping review	11
Conceptualization of quality of life in autistic individuals	11
Who benefits from diagnostic labels for developmental disorders?	11
Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi–Goutières syndrome	11
Hammersmith Infant Neurological Examination in low‐risk infants born very preterm: a longitudinal prospective study	11
Cluster headache in children and adolescents: a systematic review of case reports	11
Transition to adult services experienced by young people with cerebral palsy: A cross‐sectional study	11
Influence of sex on tic severity and psychiatric comorbidity profile in patients with pediatric tic disorder	11
Functional neurological disorder in children and young people: Incidence, clinical features, and prognosis	11
Symptomatic cervical spinal stenosis in spastic cerebral palsy	11
Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice	11

Patient engagement in an online coaching intervention for parents of children with suspected developmental delays	10
Adverse childhood experiences and developmental disabilities: risks, resiliency, and policy	10
Perinatal arterial ischemic stroke and periventricular venous infarction in infants with unilateral cerebral palsy	10
Skeletal muscle maximal mitochondrial activity in ambulatory children with cerebral palsy	10
Long‐term effects of spasticity treatment, including selective dorsal rhizotomy, for individuals with cerebral palsy	10
Sex differences in neurodevelopmental disorders	10
Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy	10
Exposure to endocrine‐disrupting chemicals and implications for neurodevelopment	10
Outcomes in influenza and RANBP2 mutation‐associated acute necrotizing encephalopathy of childhood	10
Poster Presentations	10
Influence of socioeconomic status on cognitive outcome after childhood arterial ischemic stroke	10
Development of the Fearless, Tearless Transition model of care for adolescents with an intellectual disability and/or autism spectrum disorder with mental health comorbidities	10
Dysarthria syndromes in children with cerebral palsy	10
A novel magnetic resonance imaging‐based scoring system to predict outcome in neonates born preterm with intraventricular haemorrhage	10
Neurological development of children who are HIV‐exposed and uninfected	10
Independent walking and cognitive development in preschool children with Dravet syndrome	10
Development of equations and software for estimating weight in children with cerebral palsy	10
Genotype–phenotype correlation of CACNA1A variants in children with epilepsy	10
‘You have textbooks; we have story books’. Disability as perceived by professionals and parents	10
Clinical bone health among adults with cerebral palsy: moving beyond assessing bone mineral density alone	10
Viral gene therapy for paediatric neurological diseases: progress to clinical reality	10
Gait features of dystonia in cerebral palsy	10
Diet quality in adults with cerebral palsy: a modifiable risk factor for cardiovascular disease prevention	10
The International Classification of Functioning, Disability and Health: the first 20 years	10
Cost‐effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trial	10
Neurodevelopmental profiles of children with unilateral cerebral palsy associated with middle cerebral artery and periventricular venous infarctions	10
Neonatal quantitative electroencephalography and long‐term outcomes: a systematic review	9
Neurological and cognitive outcomes after antibody‐negative autoimmune encephalitis in children	9
Dysarthria in children and adults with ataxia telangiectasia	9
Reduced mitochondrial DNA and OXPHOS protein content in skeletal muscle of children with cerebral palsy	9
Health‐related quality of life and caregiver burden after hip reconstruction and spinal fusion in children with spastic cerebral palsy	9
Single‐case experimental designs for child neurological rehabilitation and developmental disability research	9
Maternal employment and socio‐economic status of families raising children born very preterm with motor or cognitive impairments: the EPIPAGE cohort study	9
Factors associated with autism spectrum disorder in children with tuberous sclerosis complex: a systematic review and meta‐analysis	9
Long‐term outcomes of children with drug‐resistant epilepsy across multiple cognitive domains	9
Guideline to improve physical function in cerebral palsy: too big to succeed	9
Early‐onset hereditary spastic paraplegia: the possibility of a genetic diagnosis	9
Hip pain in adolescents with cerebral palsy: a population‐based longitudinal study	9
Saethre–Chotzen syndrome: long‐term outcome of a syndrome‐specific management protocol	9
Relational ethics, informed consent, and informed assent in participatory research with children with complex communication needs	9
Neurological features in infants with congenital heart disease	9
ICF Core Sets for the assessment of functioning of adults with cerebral palsy	9
Precision therapy in the genetic epilepsies of childhood	9
Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy	9
Documenting change with the Canadian Occupational Performance Measure for children with cerebral palsy	9
Stakeholder perspectives of pediatric powered wheelchair standing devices: a qualitative study	9
Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency	9
Artificial intelligence to improve efficiency of administration of gross motor function assessment in children with cerebral palsy	9
From cryogenic to on‐scalp magnetoencephalography for the evaluation of paediatric epilepsy	9
Methodological quality of systematic reviews on interventions for children with cerebral palsy: the evidence pyramid paradox	9
Neurosurgical procedures for children with myelomeningocele after fetal or postnatal surgery: a comparative effectiveness study	9
Motor performance and daily participation in children with and without probable developmental coordination disorder	9
State‐of‐the‐art therapies for Rett syndrome	9
Prenatal cytomegalovirus, rubella, and Zika virus infections associated with developmental disabilities: past, present, and future	9
Risk of early‐ and late‐onset Alzheimer disease and related dementia in adults with cerebral palsy	9
Brain malformations and cognitive performance in spina bifida	9
Self‐reported impact of developmental stuttering across the lifespan	9
Perinatal and childhood predictors of general cognitive outcome at 28 years in a very‐low‐birthweight national cohort	9
Sudden unexpected death in epilepsy in children	8
Efficacy and safety of antiseizure medication for Lennox–Gastaut syndrome: a systematic review and network meta‐analysis	8
Knowledge and attitudes of critical care providers towards neurophysiological monitoring, seizure diagnosis, and treatment	8
Fetal anomaly diagnosis and termination of pregnancy	8
Physical therapy with hippotherapy compared to physical therapy alone in children with cerebral palsy: systematic review and meta‐analysis	8
Validation of the Gait Outcomes Assessment List questionnaire and caregiver priorities for individuals with cerebral palsy	8
Neuropsychiatric phenotypes in children with Noonan syndrome	8
Factors associated with spoken language comprehension in children with cerebral palsy: a systematic review	8
Early detection of developmental delay in infants born very preterm or with very low birthweight	8
Post‐COVID‐19 scientific conferences: virtual becomes the new reality	8
Effects of voluntary exercise on muscle structure and function in cerebral palsy	8
Brain volumes and functional outcomes in children without cerebral palsy after therapeutic hypothermia for neonatal hypoxic‐ischaemic encephalopathy	8
The Dyskinetic Cerebral Palsy Functional Impact Scale: development and validation of a new tool	8
Home mechanical ventilation for children with severe neurological impairment: Parents' perspectives on clinician counselling	8
Puberty and menarche in young females with cerebral palsy and intellectual disability: a qualitative study of caregivers’ experiences	8
Neonatal neurobehavior in infants with autism spectrum disorder	8
School outcomes of adolescents with cerebral palsy in Sweden	8
Mortality in pediatric hydrocephalus	8
Impact of sleep, neuroendocrine, and executive function on health‐related quality of life in young people with craniopharyngioma	8
Interventions for children with cerebral visual impairment: A scoping review	8
Use of health services and unmet needs among adults with cerebral palsy in Ireland	8
Declining prevalence of cerebral palsy in children born at term in Denmark	8
Clinical pointers from developing self‐awareness	8
Factors associated with outcomes of severe acute necrotizing encephalopathy: A multicentre experience in Malaysia	8
Interactions between the intestinal microbiota and epigenome in individuals with autism spectrum disorder	8
Intermittent serial casting for wrist flexion deformity in children with spastic cerebral palsy: a randomized controlled trial	7
Interrater and test–retest reliability of the Hand Assessment for Infants	7
Autism questionnaire scores do not only rise because of autism	7
The Autism Symptom Dimensions Questionnaire: Development and psychometric evaluation of a new, open‐source measure of autism symptomatology	7
Rectus femoris transfer in children with cerebral palsy: comparing a propensity score‐matched observational study to a randomized controlled trial	7
Parents of children with disabilities and the COVID‐19 pandemic	7
Epidemiology and outcome of status epilepticus in children: a Scottish population cohort study	7
Recovery of HIV encephalopathy in perinatally infected children on antiretroviral therapy	7
How do we know if interventions in developmental disability are effective?	7
Elementary visuospatial perception deficit in children with neurodevelopmental disorders	7
Treatment of children with infantile spasms: A network meta‐analysis	7
Effect of sex chromosome number variation on attention‐deficit/hyperactivity disorder symptoms, executive function, and processing speed	7